Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 6.12 is 35% above its 5-year average of 4.52, around the middle of its 5-year range (1.92–10.50).
As of the fiscal period ended Tuesday, June 30, 2026. 4.40% below its 12-month average of 6.40.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.12.
QUICK RATIO (ACID-TEST)
6.12
QUICK RATIO (ACID-TEST) AVG TTM
6.40
QUICK RATIO (ACID-TEST) AVG 3Y
3.97
QUICK RATIO (ACID-TEST) AVG 5Y
4.52
QUICK RATIO (ACID-TEST) AVG 10Y
5.88
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-4.40%
CURRENT VS 3Y AVG
+54.23%
CURRENT VS 5Y AVG
+35.26%
CURRENT VS 10Y AVG
+4.12%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+82.70%
vs the sector median at left
Spero Therapeutics, Inc.
Market Cap
$68.61M
Quick Ratio (Acid-Test)
6.12
TTM Avg
6.40
3Y Avg
3.97
5Y Avg
4.52
Market Cap
$68.10M
Quick Ratio (Acid-Test)
3.83
TTM Avg
1.68
3Y Avg
1.58
5Y Avg
2.46
Market Cap
$69.36M
Quick Ratio (Acid-Test)
0.76
TTM Avg
0.89
3Y Avg
1.63
5Y Avg
3.63
Market Cap
$69.88M
Quick Ratio (Acid-Test)
1.03
TTM Avg
0.95
3Y Avg
0.86
5Y Avg
0.95
Market Cap
$70.59M
Quick Ratio (Acid-Test)
4.36
TTM Avg
4.80
3Y Avg
4.58
5Y Avg
6.22
Market Cap
$65.86M
Quick Ratio (Acid-Test)
3.50
TTM Avg
1.85
3Y Avg
1.22
5Y Avg
3.58
Market Cap
$66.01M
Quick Ratio (Acid-Test)
33.15
TTM Avg
13.79
3Y Avg
28.68
5Y Avg
44.67
Market Cap
$65.38M
Quick Ratio (Acid-Test)
0.53
TTM Avg
4.76
3Y Avg
5.20
5Y Avg
7.10
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | $68.61M | 6.12 | 6.40 | 3.97 | 4.52 |
| Fortress Biotech, Inc. (FBIO)vs › | $68.10M | 3.83 | 1.68 | 1.58 | 2.46 |
| Tiziana Life Sciences Ltd (TLSA)vs › | $69.36M | 0.76 | 0.89 | 1.63 | 3.63 |
| Champions Oncology, Inc. (CSBR)vs › | $69.88M | 1.03 | 0.95 | 0.86 | 0.95 |
| iBio, Inc. (IBIO)vs › | $67.52M | 7.85 | 4.72 | 3.68 | 5.30 |
| Gain Therapeutics, Inc. (GANX)vs › | $70.59M | 4.36 | 4.80 | 4.58 | 6.22 |
| Cingulate Inc. (CING)vs › | $65.86M | 3.50 | 1.85 | 1.22 | 3.58 |
| XBiotech Inc. (XBIT)vs › | $66.01M | 33.15 | 13.79 | 28.68 | 44.67 |
| Gossamer Bio, Inc. (GOSS)vs › | $65.38M | 0.53 | 4.76 | 5.20 | 7.10 |
| MindWalk Holdings Corp. (HYFT)vs › | $72.60M | 1.75 | 2.29 | 2.05 | 3.32 |
Quick Ratio
6.12
Excludes inventory
Current Ratio
6.12
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 6.12 |
| 2026-03-31 | 10.50 |
| 2025-12-31 | 7.59 |
| 2025-09-30 | 3.83 |
| 2025-06-30 | 3.97 |
| 2025-03-31 | 2.56 |
| 2024-12-31 | 2.19 |
| 2024-09-30 | 2.68 |
| 2024-06-30 | 2.68 |
| 2024-03-31 | 3.35 |
| 2023-12-31 | 3.53 |
| 2023-09-30 | 4.01 |
| 2023-06-30 | 5.10 |
| 2023-03-31 | 4.42 |
| 2022-12-31 | 5.25 |
| 2022-09-30 | 3.26 |
| 2022-06-30 | 3.65 |
| 2022-03-31 | 1.92 |
| 2021-12-31 | 8.46 |
| 2021-09-30 | 7.64 |
| 2021-06-30 | 8.29 |
| 2021-03-31 | 7.29 |
| 2020-12-31 | 9.70 |
| 2020-09-30 | 8.12 |
| 2020-06-30 | 4.49 |
| 2020-03-31 | 4.31 |
| 2019-12-31 | 3.58 |
| 2019-09-30 | 6.90 |
| 2019-06-30 | 13.66 |
| 2019-03-31 | 17.48 |
| 2018-12-31 | 10.08 |
| 2018-09-30 | 13.01 |
| 2018-06-30 | 10.68 |
| 2018-03-31 | 13.67 |
| 2017-12-31 | 11.29 |
| 2017-09-30 | 3.92 |
| 2017-06-30 | 5.85 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 1.72 |
| 2016-09-30 | 0.00 |
